FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.

The transcription factor Forkhead box M1 (FoxM1) is overexpressed in malignant glioma. However, the functional importance of this factor in human glioma is not known. In the present study, we found that FoxM1B was the predominant FoxM1 isoform expressed in human glioma but not in normal brain tissue. The level of FoxM1 protein expression in human glioma tissues was directly correlated with the glioma grade. The level of FoxM1 protein expression in human glioblastoma tissues was inversely correlated with patient survival. Enforced FoxM1B expression caused SW1783 and Hs683 glioma cells, which do not form tumor xenografts, to regain tumorigenicity in nude mouse model systems. Moreover, gliomas that arose from FoxM1B-transfected anaplastic astrocytoma SW1783 cells displayed glioblastoma multiforme phenotypes. Inhibition of FoxM1 expression in glioblastoma U-87MG cells suppressed their anchorage-independent growth in vitro and tumorigenicity in vivo. Furthermore, we found that FoxM1 regulates the expression of Skp2 protein, which is known to promote degradation of the cell cycle regulator p27(Kip1). These results showed that FoxM1 is overexpressed in human glioblastomas and contributes to glioma tumorigenicity. Therefore, FoxM1 might be a new potential target of therapy for human malignant gliomas.

[1]  M. West,et al.  Gene expression profiling and genetic markers in glioblastoma survival. , 2005, Cancer research.

[2]  R. Costa,et al.  Premature Expression of the Winged Helix Transcription Factor HFH-11B in Regenerating Mouse Liver Accelerates Hepatocyte Entry into S Phase , 1999, Molecular and Cellular Biology.

[3]  David E. Misek,et al.  Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. , 2003, The American journal of pathology.

[4]  Fang Tan,et al.  The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  M. Teh,et al.  FOXM1 is a downstream target of Gli1 in basal cell carcinomas. , 2002, Cancer research.

[6]  David E. Misek,et al.  Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. , 2001, Cancer research.

[7]  Michele Pagano,et al.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.

[8]  C. N. Rao,et al.  A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion , 2001, Oncogene.

[9]  M. Follettie,et al.  Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. , 2005, Cancer research.

[10]  V. Fiano,et al.  Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blot , 2002, Neuroscience Letters.

[11]  B. Futcher,et al.  Human D-type cyclin , 1991, Cell.

[12]  W. Yung,et al.  The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  A. Datta,et al.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. , 2004, Genes & development.

[14]  G. Adami,et al.  Increased Hepatic Forkhead Box M1B (FoxM1B) Levels in Old-aged Mice Stimulated Liver Regeneration through Diminished p27Kip1 Protein Levels and Increased Cdc25B Expression* , 2002, The Journal of Biological Chemistry.

[15]  M. Henriksson,et al.  Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation , 1999, Oncogene.

[16]  G. Reifenberger,et al.  The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.

[17]  D. Louis.  The p53 Gene and Protein in Human Brain Tumors , 1994, Journal of neuropathology and experimental neurology.

[18]  Karlyne M. Reilly,et al.  Genetically engineered mouse models of astrocytoma: GEMs in the rough? , 2001, Seminars in cancer biology.

[19]  L. Gerace,et al.  Cloning of cDNAs for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Polyak,et al.  p27KIP1, an inhibitor of cyclin-dependent kinases. , 1995, Progress in cell cycle research.

[21]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[22]  W. Cavenee,et al.  Molecular biology of malignant degeneration of astrocytoma. , 1996, Pediatric neurosurgery.

[23]  Hans Clevers,et al.  FoxM1 is required for execution of the mitotic programme and chromosome stability , 2005, Nature Cell Biology.

[24]  K. Aldape,et al.  Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.

[25]  E. Holland,et al.  Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis. , 2005, Cancer research.

[26]  L. R. Bridges,et al.  Cyclin D1 in astrocytic tumours: an immunohistochemical study , 1996, Neuropathology and applied neurobiology.

[27]  J. Olson,et al.  Analysis of cyclin dependent kinase inhibitors in malignant astrocytomas. , 1999, International journal of oncology.

[28]  D. Schiffer,et al.  p27/kip1 expression in human astrocytic gliomas , 1997, Neuroscience Letters.

[29]  K. Kinzler,et al.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Lim,et al.  Hepatocyte Nuclear Factor 3 / fork head Homolog 11 Is Expressed in Proliferating Epithelial and Mesenchymal Cells of Embryonic and Adult Tissues , 1996 .

[31]  Faith Davis,et al.  Brain tumor survival: Results from the National Cancer Data Base , 1998, Journal of Neuro-Oncology.

[32]  E. Alvord.  Is Necrosis Helpful in the Grading of Gliomas? Editorial Opinion , 1992, Journal of neuropathology and experimental neurology.

[33]  H. Clevers,et al.  The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization. , 1997, Genomics.

[34]  P. Pandolfi,et al.  Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. , 2002, Cancer cell.

[35]  K. Yao,et al.  Molecular Analysis of a Novel Winged Helix Protein, WIN , 1997, The Journal of Biological Chemistry.

[36]  H. Kiyokawa,et al.  The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  F. McCormick,et al.  Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells , 2005, Journal of Molecular Medicine.

[38]  M. Tainsky,et al.  Loss of AP‐2 results in downregulation of c‐KIT and enhancement of melanoma tumorigenicity and metastasis , 1998, The EMBO journal.

[39]  R. DePinho,et al.  Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.

[40]  D. Bigner,et al.  Molecular pathogenesis of malignant gliomas. , 1999, Current opinion in oncology.

[41]  D. Dinh,et al.  A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. , 2001, International journal of oncology.

[42]  H. Haapasalo,et al.  Low expression of p27 indicates a poor prognosis in patients with high‐grade astrocytomas , 2003, Cancer.

[43]  R. Nho,et al.  p27kip1 contributions to cancer. , 2003, Progress in cell cycle research.

[44]  S. Shankland,et al.  Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1). , 1999, The Journal of clinical investigation.

[45]  H. Clevers,et al.  Uncoupling of S phase and mitosis in cardiomyocytes and hepatocytes lacking the winged-helix transcription factor Trident , 1998, Current Biology.

[46]  H. Clevers,et al.  The winged-helix transcription factor Trident is expressed in cycling cells. , 1997, Nucleic acids research.

[47]  K. Aldape,et al.  Expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Expression of Vascular Endothelial Growth Factor in and Angiogenic Phenotype of Human Gastric Cancer , 2005, Clinical Cancer Research.

[48]  Chong Sze Tong,et al.  Over‐expression of FoxM1 stimulates cyclin B1 expression , 2001, FEBS letters.

[49]  K. Hess,et al.  Identification of Necrosis-Associated Genes in Glioblastoma by cDNA Microarray Analysis , 2004, Clinical Cancer Research.

[50]  G. Fuller,et al.  An implantable guide-screw system for brain tumor studies in small animals. , 2000, Journal of neurosurgery.